The Company approved the transfer of 21,000 of the existing 7th Series Stock Acquisition Rights held by each of Seacastle Singapore and Horizon Investment, for a total of 42,000 rights, to 有限会社ＮＯＣＣＡ. There are no changes to the exercise terms or issuance terms.
Approval of the transfer of the 7th Series Stock Acquisition Rights
42,000 stock acquisition rights (100 shares per right; 4,200,000 potential shares)
The lower thin line represents the existing number of shares to which these shares will be added.
¥7,235,602,436 in expected proceeds at issuance (estimated net proceeds: Not disclosed)
| Item | Details |
|---|---|
| Type of issuance or disposal | Approval of the transfer of the 7th Series Stock Acquisition Rights |
| Number of shares to be issued or disposed of | 42,000 stock acquisition rights (100 shares per right; 4,200,000 potential shares) |
| Amount of funds to be raised | ¥7,235,602,436 in expected proceeds at issuance (estimated net proceeds: Not disclosed) |
| Specific use of funds | Details Funds for M&A and capital and business alliances / Amount ¥1,450 million / Scheduled timing of expenditures August 2025 to July 2028, Details Working capital for the Company's subsidiary, GoldStar Co., Ltd. / Amount ¥1,700 million / Scheduled timing of expenditures August 2025 to July 2028, Details Working capital (361° business) / Amount ¥950 million / Scheduled timing of expenditures August 2025 to July 2028, Details Working capital (sustainable business) / Amount ¥3,088 million / Scheduled timing of expenditures August 2025 to July 2028 |
| Payment date | 29 August 2025 (at issuance) |
| Intended allottee | Name 有限会社ＮＯＣＣＡ / Number of Shares 42,000 stock acquisition rights; 4,200,000 potential shares |
| Intended allottee's holding policy | The transferee intends to hold the Company's shares over the medium to long term after exercising the stock acquisition rights. |
| Total number of issued shares | 38,950,000 shares (at the offering) → Not disclosed |
| Exercise price | Initial exercise price: ¥95 per share. Adjustment provisions: Not disclosed (unchanged by this transfer) |
| Number of Stock Acquisition Rights | Total issued: 741,049 rights; unexercised balance as of the current date: Not disclosed (exercise status as of the current date: 13,036,100 shares) |
| Procedures under the Corporate Code of Conduct | The Board of Directors carefully considered the transferee, the purpose of the transfer and its impact on the Company's management, among other factors, in an overall assessment. |
| Most recent equity financing | Timing Announced on 1 August 2025; payment date: 29 August 2025 / Type Issuance of new shares and the 7th Series Stock Acquisition Rights through a third-party allotment / Amount Total issue price of the stock acquisition rights: ¥195,636,936; expected proceeds at issuance: ¥7,235,602,436 |
| Impact on Business Performance | The impact is currently under review, and the Company will promptly disclose any matter requiring disclosure. |
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The Company stated that, given the gap between the share price and the exercise price, the purpose is to encourage the transferee to exercise the stock acquisition rights, thereby increasing the likelihood of financing and making future flexible fundraising more certain.